NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/14/2025
Back to search
Official data from USPTO
PUFFEPINEPHRIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PUFFEPINEPHRIN
ST13
US500000088797750Class
5, 10
Filing
88797750
Registration
7980026
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
67
Latest update
04/03/2026
Trademark type
Word
Nice classes
5, 10
Filing date
02/14/2020
Registration date
10/14/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/14/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
RICHMOND, CA
Examiner
JACKSON, STEVEN W
Law office
L70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
KOKUA PHARMA INC.
1232176 B.C. Ltd.
Representatives
Douglas R. Wolf Wolf Greenfield & Sacks, P.C.
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
inhaled pharmaceutical preparations for the treatment of anaphylaxis and respiratory disorders
Class 10
inhalers for therapeutic use
Publications
History of USPTO decisions and trademark events.
67 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/14/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/26/2025
PUBO
PUBLISHED FOR OPPOSITION
08/26/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/20/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/17/2025
DMCC
DATA MODIFICATION COMPLETED
07/16/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/15/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/15/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/15/2025
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
05/05/2025
GNSI
INQUIRY TO SUSPENSION E-MAILED
05/05/2025
CNSI
SUSPENSION INQUIRY WRITTEN
05/05/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/04/2024
GNSL
LETTER OF SUSPENSION E-MAILED
11/04/2024
CNSL
SUSPENSION LETTER WRITTEN
11/04/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/08/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/26/2023
GNSL
LETTER OF SUSPENSION E-MAILED
12/26/2023
CNSL
SUSPENSION LETTER WRITTEN
12/26/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/26/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/26/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12/22/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
09/28/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
09/28/2023
CNSI
SUSPENSION INQUIRY WRITTEN
09/28/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
09/27/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02/17/2023
GNSL
LETTER OF SUSPENSION E-MAILED
02/17/2023
CNSL
SUSPENSION LETTER WRITTEN
02/17/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/16/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/16/2023
ALIE
ASSIGNED TO LIE
02/15/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/08/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/29/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/29/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/29/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/29/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/29/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/29/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
08/24/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
08/24/2022
CNSI
SUSPENSION INQUIRY WRITTEN
08/24/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
08/23/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02/17/2022
GNSL
LETTER OF SUSPENSION E-MAILED
02/17/2022
CNSL
SUSPENSION LETTER WRITTEN
02/17/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/16/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/16/2022
ALIE
ASSIGNED TO LIE
02/16/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/11/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
08/16/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
08/16/2021
CNSI
SUSPENSION INQUIRY WRITTEN
08/16/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
08/11/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/09/2020
GNSL
LETTER OF SUSPENSION E-MAILED
11/09/2020
CNSL
SUSPENSION LETTER WRITTEN
11/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/07/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/06/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/06/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/12/2020
GNRT
NON-FINAL ACTION E-MAILED
05/12/2020
CNRT
NON-FINAL ACTION WRITTEN
05/12/2020
DOCK
ASSIGNED TO EXAMINER
05/06/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/20/2020
NWAP
NEW APPLICATION ENTERED
02/18/2020
Continuous trademark protection
Get notified about every new filing that threatens PUFFEPINEPHRIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.